[1]
“Analysis of users of pre-exposure risk prophylaxis for human immunodeficiency virus in the northern region of Brazil, 2018 – 2023”, Acervo Saúde, vol. 25, p. e19918, Apr. 2025, doi: 10.25248/reas.e19918.2025.